MoneyWorks4Me

Mercury Laboratories informs about outcome of board meeting

11 Feb 2026 Evaluate
Mercury Laboratories has informed that the Board of Directors at its meeting held today on Wednesday, February 11, 2026 approved the Unaudited Financial Results of the Company for the quarter and nine months ended on December 31, 2025. Accordingly, it enclosed Unaudited Financial Results for the quarter and nine months ended on December 31, 2025; Limited Review Report by Statutory Auditors on the Unaudited Financial Results. The time of commencement of the Board Meeting was 9:00 am (IST) and the time of conclusion was 11.15 am (IST).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1847.70
Dr. Reddys Labs. 1243.10
Cipla 1386.55
Lupin 2074.70
Zydus Lifesciences 1217.30
View more..